financetom
VALU
financetom
/
Financials
/
VALU
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Value Line, Inc.VALU
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Value Line, Inc. produces and sells investment periodicals and related publications.

Its investment periodicals and related publications cover a range of investments, including stocks, mutual funds, exchange traded funds (ETFs), and options.

The company's research services include The Value Line Investment Survey, The Value Line Investment Survey - Small and Mid-Cap, The Value Line 600, and The Value Line Fund Advisor Plus that provide statistical and text coverage of various investment securities, with an emphasis placed on its proprietary research, analysis, and statistical ranks.

It also provides niche newsletters comprising Value Line Select: Dividend Income & Growth, Value Line Select: ETFs, The Value Line Special Situations Service, The Value Line M&A Service, The Value Line Climate Change Investing Service, and The Value Line Information You Should Know Wealth Newsletter that offer information on a less comprehensive basis for securities that are of particular interest to subscribers; digital versions of its products through its Website, www.valueline.com; The Value Line Research Center online platform; and investment analysis software, such as The Value Line Investment Analyzer and The New Value Line ETFs Service.

In addition, the company offers current and historical financial databases comprising fundamental DataFile, estimates and projections, and mutual funds; and copyright products, which include unit investment trusts, variable annuities, managed accounts, and ETFs.

Further, it operates as publishing unit for the investment related periodical publications and copyrights; places advertising on behalf of the company's publications; and distributes print publications.

It serves individual and professional investors, as well as institutions, including municipal and university libraries, and investment firms.

The company was founded in 1931 and is headquartered in New York, New York. Value Line, Inc. is a subsidiary of Arnold Bernhard & Co., Inc.

Latest News >
Zoom Video Reports Better-Than-Expected Q2 Results, Strong Forward Guidance: Details
Zoom Video Reports Better-Than-Expected Q2 Results, Strong Forward Guidance: Details
Aug 22, 2024
Zoom Video Communications, Inc. ( ZM ) shares are trading higher Wednesday after the company posted better-than-expected second-quarter financial results. Here's a look at the details from the report.  The Details: Zoom reported quarterly earnings of $1.39 per share which beat the analyst consensus estimate of $1.21 by 14.88%. Quarterly revenue of $1.16 billion also beat the consensus estimate and...
NASA says decision on Boeing Starliner crew's path home coming Saturday
NASA says decision on Boeing Starliner crew's path home coming Saturday
Aug 22, 2024
WASHINGTON, Aug 22 (Reuters) - NASA on Thursday said it expects to announce on Saturday its decision on whether the two astronauts who rode Boeing's ( BA ) glitchy Starliner spacecraft to the International Space Station will need a SpaceX vehicle to return to Earth. ...
Microsoft cuts first-quarter intelligent cloud revenue forecast
Microsoft cuts first-quarter intelligent cloud revenue forecast
Aug 22, 2024
Aug 21 (Reuters) - Microsoft ( MSFT ) on Wednesday cut its first-quarter intelligent cloud forecast, the technology giant said in an investor presentation. The company now expects intelligent cloud revenue to be between $23.80 billion and $24.10 billion, compared with its prior expectations of $28.6 billion and $28.9 billion. (Reporting by Jaspreet Singh in Bengaluru; Editing by Arun Koyyur)...
Zenas BioPharma Launches Nasdaq IPO
Zenas BioPharma Launches Nasdaq IPO
Aug 22, 2024
03:47 PM EDT, 08/22/2024 (MT Newswires) -- Zenas BioPharma (ZBIO) said Thursday that it launched an initial public offering of its common stock. The company applied to list its shares on the Nasdaq Global Market under the symbol ZBIO. Zenas said it plans to use the net proceeds from the IPO to advance the clinical development of obexelimab and the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved